We have located links that may give you full text access.
Impact of Deceased Donor Management on Donor Heart Use and Recipient Graft Survival.
Journal of the American College of Surgeons 2020 June 18
BACKGROUND: Current risk-adjusted models used to predict donor heart utilization and cardiac graft survival from organ donors after brain death (DBDs) do not include bedside critical care data. We sought to identify novel independent predictors of heart utilization and graft survival to better understand the relationship between donor management and transplant outcomes.
STUDY DESIGN: Prospective observational study of DBDs managed from 2008 to 2013 by 10 organ procurement organizations. Demographic data, critical care parameters, and treatments were recorded at three standardized time points during donor management. The primary outcome measures were donor heart utilization and cardiac graft survival.
RESULTS: From 3,433 DBDs, 1,134 (33%) hearts were transplanted and 969 (85%) cardiac grafts survived after 684 (± 392) days of follow-up. After multivariable analysis, independent positive predictors of heart utilization included standard criteria donor status (OR = 3.93), male sex (OR = 1.68), ejection fraction > 50% (OR = 1.64), and PaO2 :FiO2 > 300 (OR = 1.31). Independent negative predictors of heart utilization included donor age (OR = 0.94), body mass index > 30 kg/m2 (OR = 0.78), serum creatinine (OR = 0.83), and use of thyroid hormone (OR = 0.78). As for graft survival, after controlling for known recipient risk factors, thyroid hormone dose was the only independent predictor (OR = 1.04 per μg/hr).
CONCLUSION: Modifiable critical care parameters and treatments predict donor heart utilization and cardiac graft survival. The discordant relationship between thyroid hormone and donor heart utilization (negative predictor) versus cardiac graft survival (positive predictor) warrants further investigation.
STUDY DESIGN: Prospective observational study of DBDs managed from 2008 to 2013 by 10 organ procurement organizations. Demographic data, critical care parameters, and treatments were recorded at three standardized time points during donor management. The primary outcome measures were donor heart utilization and cardiac graft survival.
RESULTS: From 3,433 DBDs, 1,134 (33%) hearts were transplanted and 969 (85%) cardiac grafts survived after 684 (± 392) days of follow-up. After multivariable analysis, independent positive predictors of heart utilization included standard criteria donor status (OR = 3.93), male sex (OR = 1.68), ejection fraction > 50% (OR = 1.64), and PaO2 :FiO2 > 300 (OR = 1.31). Independent negative predictors of heart utilization included donor age (OR = 0.94), body mass index > 30 kg/m2 (OR = 0.78), serum creatinine (OR = 0.83), and use of thyroid hormone (OR = 0.78). As for graft survival, after controlling for known recipient risk factors, thyroid hormone dose was the only independent predictor (OR = 1.04 per μg/hr).
CONCLUSION: Modifiable critical care parameters and treatments predict donor heart utilization and cardiac graft survival. The discordant relationship between thyroid hormone and donor heart utilization (negative predictor) versus cardiac graft survival (positive predictor) warrants further investigation.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.Journal of the American College of Cardiology 2024 March 3
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app